Closes Nov 18, 2027Up to $300K
Chemical Countermeasures Research Program (CCRP) Initiative: Basic Research on The Deleterious Effects of Acute Exposure to Ultra-Potent Synthetic (UPS) Opioids (R01 Clinical Trial Not Allowed)
- Agency
- National Institutes of Health
- Eligible locations
- Nationwide